Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5951
Enanta Pharmaceuticals
ENTA
$380M
| $13K | ﹤0.01% |
2,403
-218
| -8% | -$1.35K |
|
5952
iShares MSCI Japan Value ETF
EWJV
$754M
| $13K | ﹤0.01% |
394
-506
| -56% | -$16.5K |
|
5953
First US Bancshares
FUSB
$90.8M
| $13K | ﹤0.01% |
1,000
-14
| -1% | -$183 |
|
5954
Gevo
GEVO
$420M
| $13K | ﹤0.01% |
11,259
+10,869
| +2,787% | +$18.2K |
|
5955
Groupon
GRPN
$883M
| $13K | ﹤0.01% |
656
-1,300
| -66% | -$16.5K |
|
5956
Heritage Global
HGBL
$37.5M
| $13K | ﹤0.01% |
6,186
-8,415
| -58% | -$17.9K |
|
5957
Kaltura
KLTR
$244M
| $13K | ﹤0.01% |
7,276
-953
| -12% | -$2.13K |
|
5958
Lifetime Brands
LCUT
$224M
| $13K | ﹤0.01% |
2,551
+184
| +8% | +$997 |
|
5959
LiveWire
LVWR
$260M
| $13K | ﹤0.01% |
6,423
+2,460
| +62% | +$7.17K |
|
5960
Navitas Semiconductor
NVTS
$3.84B
| $13K | ﹤0.01% |
6,389
-7,681
| -55% | -$22K |
|
|
PBPB
5961
DELISTED
Potbelly
PBPB
| $13K | ﹤0.01% |
1,356
-3,168
| -70% | -$35K |
|
5962
Precigen
PGEN
$2.26B
| $13K | ﹤0.01% |
8,996
-9,478
| -51% | -$14.9K |
|
5963
Playboy Inc
PLBY
$151M
| $13K | ﹤0.01% |
12,496
-4,044
| -24% | -$6.32K |
|
5964
Invesco S&P SmallCap Consumer Discretionary ETF
PSCD
$24.3M
| $13K | ﹤0.01% |
144
| – | – |
|
5965
Perella Weinberg Partners
PWP
$1.3B
| $13K | ﹤0.01% |
713
-24,493
| -97% | -$556K |
|
|
RENT
5966
Rent the Runway
RENT
$118M
| $13K | ﹤0.01% |
3,000
+2,692
| +874% | +$17.9K |
|
|
SLRN
5967
DELISTED
ACELYRIN
SLRN
| $13K | ﹤0.01% |
5,263
-17,265
| -77% | -$41.1K |
|
5968
CALL
TransAlta
TAC
$4.04B
| $13K | ﹤0.01% |
1,400
-110,200
| -99% | -$1.22M |
|
|
TBI
5969
Trueblue
TBI
$316M
| $13K | ﹤0.01% |
2,316
-1,587
| -41% | -$10.8K |
|
|
WW
5970
DELISTED
WW International
WW
| $13K | ﹤0.01% |
24,600
+17,565
| +250% | +$15.3K |
|
5971
NEOS Nasdaq 100 High Income ETF
QQQI
$14.1B
| $13K | ﹤0.01% |
258
+166
| +180% | +$8.57K |
|
|
TE
5972
T1 Energy
TE
$1.54B
| $13K | ﹤0.01% |
10,736
-3,522
| -25% | -$6.5K |
|
|
IBHK
5973
iShares iBonds 2031 Term High Yield and Income ETF
IBHK
$72.8M
| $13K | ﹤0.01% |
486
-45
| -8% | -$1.15K |
|
|
RAPP
5974
Rapport Therapeutics
RAPP
$2.25B
| $13K | ﹤0.01% |
1,311
+319
| +32% | +$4.14K |
|
5975
Atossa Therapeutics
ATOS
$25.7M
| $12K | ﹤0.01% |
1,169
-25
| -2% | -$304 |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.